Literature DB >> 6180250

Failure of human benign prostatic hyperplasia to aromatise testosterone.

T Smith, G D Chisholm, F K Habib.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6180250     DOI： 10.1016/0022-4731(82)90601-x

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN： 0022-4731            Impact factor:   4.292


× No keyword cloud information.
  4 in total

1.  Testosterone metabolism in primary cultures of epithelial cells and stroma from benign prostatic hyperplasia.

Authors:  M Tsugaya; F K Habib; G D Chisholm; M Ross; K Tozawa; Y Hayashi; K Kohri; S Tanaka
Journal:  Urol Res       Date:  1996

Review 2.  Estrogen and androgen signaling in the pathogenesis of BPH.

Authors:  Clement K M Ho; Fouad K Habib
Journal:  Nat Rev Urol       Date:  2011-01       Impact factor: 14.432

Review 3.  Formestane. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of breast cancer and prostatic cancer.

Authors:  L R Wiseman; D McTavish
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

4.  Aromatase inhibition in advanced prostatic cancer: preliminary communication.

Authors:  R J Shearer; J H Davies; M Dowsett; P R Malone; A Hedley; D Cunningham; R C Coombes
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.